authors
- KRISTENSEN, GB
- VERGOTE, I
- STUART, G
- del CAMPO, JM
- KAERN, J
- BAEKELANDT, M
- LOPEZ, AB
- Hirte, Holger
- AAVALL-LUNDQVIST, E
- LORENZ, E
- CERAR, O
First-line treatment of ovarian/tubal/peritoneal cancer FIGO stage IIB-IV with paclitaxel/carboplatin with or without epirubicin (TEC vs TC). A gynecologic cancer intergroup study of the NSGO, EORTC GCG, and NCIC CTG. Results on progression-free survival
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- November 2005
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)